Evidence map›Paper›PMID 24776644›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2014

Superficial scrapings from breast tumors is a source for biobanking and research purposes.

Ran Ma, Irma Fredriksson, Govindasamy-Muralidharan Karthik, Gregory Winn, Eva Darai-Ramqvist, Jonas Bergh, Johan Hartman

Abstract read
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ran MaDepartments of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
Irma Fredriksson1] Departments of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden [2] Departments of Breast and Endocrine Surgery, Karolinska Institutet, Stockholm, Sweden.
Govindasamy-Muralidharan KarthikDepartments of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
Gregory WinnDepartments of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
Eva Darai-RamqvistDepartments of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
Jonas Bergh1] Departments of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden [2] Radiumhemmet - Karolinska Oncology, Karolinska University Hospital, Stockholm, Sweden.
Johan Hartman1] Departments of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden [2] Departments of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a unique tumor disease in terms of the stringent requirement of predictive biomarker assessments. As recommended by current international guidelines, the established markers consist of estrogen receptor (ER), progesterone receptor, human epidermal growth factor and Ki67, and are primarily analyzed by immunohistochemistry. However, new diagnostic methods based on microarray or next-generation sequencing on DNA and mRNA level are gaining ground. These analyses require fresh-frozen tumor tissue that is generally not available from tumors <10 mm in diameter, comprising almost 25% of all resected breast cancer at our department. We here present a simple and standardized method to generate material from small tumors without risking the histopathological examination. Furthermore, we show that the quality of this material is sufficient for subsequent analysis on mRNA, DNA, and epigenetic level. We were also able to use this method for isolation and expansion of cancer stem cells from the majority of tumors. Consequently, researches can be provided with clinically relevant material for translational studies. In conclusion, this method opens up a new possibility for usage of valuable fresh tumor material for research purposes, biobanking, and next-generation sequencing.

Indexed as

Biological Specimen BanksBiomedical ResearchBreast NeoplasmsDNA MethylationDNA, NeoplasmFemaleHumansNeoplastic Stem CellsPathology, MolecularReproducibility of ResultsRNA, NeoplasmSequence Analysis, DNASpecimen HandlingDNA, NeoplasmRNA, Neoplasm

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.